Suchergebnisse - "Forman, Seth"

PubPharm (62)

1

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis : A randomized, double-blinded, vehicle-controlled, phase 3 trial

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Draelos, Z. | Stein Gold, L. | +18

2

ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure : Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201

enthalten in: JID innovations : skin science from molecules to population health | 2024

von Changelian, P. | Xu, C. | Mnich, S. | +19

3

Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa

enthalten in: NEJM evidence | 2024

von Kimball, A. | Peeva, E. | Forman, S. | +7

4

Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis : A Randomized Clinical Trial

enthalten in: JAMA dermatology | 2024

von Eichenfield, L. | Tarabar, S. | Forman, S. | +7

5

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity : The SURMOUNT-4 Randomized Clinical Trial

enthalten in: JAMA | 2024

von Aronne, L. | Sattar, N. | Horn, D. | +85

6

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis : A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

enthalten in: JAMA dermatology | 2023

von Zirwas, M. | Draelos, Z. | DuBois, J. | +21

7

Long-term safety and disease control with ruxolitinib cream in atopic dermatitis : Results from two phase 3 studies

enthalten in: Journal of the American Academy of Dermatology | 2023

von Papp, K. | Szepietowski, J. | Kircik, L. | +8

8

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

enthalten in: The New England journal of medicine | 2023

von Silverberg, J. | Guttman-Yassky, E. | Thaçi, D. | +110

CommentIn: N Engl J Med. 2023 Jun 15;388(24):2299. - PMID 37314718

9

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis : A Randomized Clinical Trial (ADhere)

enthalten in: JAMA dermatology | 2023

von Simpson, E. | Gooderham, M. | Wollenberg, A. | +66

ErratumIn: JAMA Dermatol. 2023 Sep 1;159(9):1014. - PMID 37466974

10

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

enthalten in: The New England journal of medicine | 2022

von Rosmarin, D. | Passeron, T. | Pandya, A. | +109

CommentIn: N Engl J Med. 2022 Oct 20;387(16):1515-1516. - PMID 36260796

1
2
3
4
5
6
7
Nächster »
[7]